Rameez Sayyed, MD
Cardiovascular Disease · Huntington, WVNPI 1811956659
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (58.4%), travel and lodging and education — rather than concentrated in one kind of arrangement. 32 manufacturers reported payments, led by Medtronic at 47.7% of the total. Reporting peaked in 2023 at $11,046 and has fallen 80.0% since, to $2,208 in 2025. Among cardiovascular disease clinicians in WV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 300 payments — averaging $70.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$10K
- Endologix LLC$2K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$1K
- Shockwave Medical, Inc$1K
- Penumbra, Inc.$874
- Abbott$696
- plus $5K from 26 others
What the payments were for
- Travel & lodging$8,72741%
- Food & beverage$12,41158%
- Education$1000%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 52 | $10,134 |
| Endologix LLC | 16 | $1,840 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 88 | $1,391 |
| Shockwave Medical, Inc | 18 | $1,156 |
| Penumbra, Inc. | 11 | $874 |
| Abbott | 13 | $696 |
| Abiomed | 8 | $644 |
| Boston Scientific | 17 | $630 |
| Terumo Medical Corporation | 7 | $550 |
| AstraZeneca | 9 | $499 |
| Inari Medical, Inc. | 2 | $383 |
| Edwards Lifesciences | 3 | $295 |
| Heartflow, Inc. | 3 | $284 |
| Johnson & Johnson | 13 | $268 |
| Bolton Medical Inc | 2 | $245 |
| Celonova Biosciences, Inc. | 1 | $237 |
| Novartis | 10 | $148 |
| Boehringer Ingelheim | 3 | $141 |
| Inspire Medical Systems, Inc. | 1 | $138 |
| Chiesi USA, Inc. | 1 | $126 |
| ZOLL Circulation Inc | 2 | $112 |
| W. L. Gore & Associates, Inc. | 1 | $106 |
| Pfizer | 5 | $67 |
| Angiodynamics, Inc. | 1 | $59 |
| Amgen | 4 | $51 |
| Philips North America LLC | 2 | $39 |
| Kestra Medical Technology Services, Inc. | 1 | $36 |
| Cardiva Medical, Inc. | 2 | $31 |
| Fortis Surgical, LLC | 1 | $16 |
| GE HealthCare | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IN.PACT Admiral$7,617
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$857
- Indigo System$823
- TurboHawk$803
- AFX$647
- Ovation$525
- Impella$374
- FlowTriever$372
- ClotTriever$372
- AFX2 Bifurcated Endograft System$361
- SAPIEN 3 Ultra RESILIA$268
- Abre$255
- TREO ABDOMINAL STENT-GRAFT SYSTEM$245
- METACROSS OTW$232
- HawkOne$229
- Alto Abdominal Stent Graft System$221
- CARDIOMEMS$170
- FFRct$143
- Inspire$138
- Xience Sierra Coronary Stent System$130
How this compares
$21,238 in reported general payments places this provider in the 90th percentile of 100 cardiovascular disease providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 51 | $55,527 |
| EntrestoSacubitril/Valsartan | 32 | $32,793 |
| BrilintaTicagrelor | 38 | $23,170 |
| Ranolazine ErRanolazine | 24 | $1,950 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 124 | $1,264 |
| ClopidogrelClopidogrel Bisulfate | 122 | $1,122 |
| Metoprolol Succinate | 95 | $884 |
| Atorvastatin Calcium | 91 | $647 |
| Carvedilol | 43 | $475 |
| Lisinopril | 86 | $386 |
| Amlodipine Besylate | 74 | $344 |
| Diltiazem Hcl | 12 | $339 |
| Rosuvastatin Calcium | 50 | $338 |
| Atenolol | 55 | $231 |
| Losartan Potassium | 29 | $186 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $67 | $55,52751 claims |
| NovartisEntresto | $148 | $32,79332 claims |
| AstraZenecaBrilinta | $499 | $23,17038 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 100 cardiovascular disease providers in West Virginia.
Other cardiovascular disease in Huntington
- Kofi OseiHuntington$87K
- Esam BaryunHuntington$55K
- Jason MaderHuntington$13K
- Samian SulaimanHuntington$7K
- Mark StudenyHuntington$7K
- Ellen ThompsonHuntington$6K
- Amrit ThakurHuntington$5K
- Mehiar El-HamdaniHuntington$4K
- George LinsenmeyerHuntington$2K
- Sarah RinehartCharleston$303K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.